Trials / Conditions / Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
3 registered clinical trials studyying Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Epcoritamab, Rituximab, Gemcitabine and Oxaliplatin (R-GemOx) as Salvage Therapy Before Autologous Stem Cell T NCT07365306 | City of Hope Medical Center | Phase 2 |
| Recruiting | Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T NCT06784726 | University of Washington | Phase 2 |
| Recruiting | Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymp NCT05672251 | City of Hope Medical Center | Phase 2 |